PetVivo Holdings, Inc. (PETVW) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
Address
5251 Edina Industrial Boulevard
Minneapolis, MN 55439
United States of America (the)
Phone
952 405 6216
Website
Sector
Healthcare
Industry
Medical - Devices
Employees
20
First IPO Date
August 11, 2021
| Name | Title | Pay | Year Born |
| John Lai | Chief Executive Officer, President & Director | 195,579 | 1962 |
| John F. Dolan | General Counsel, Chief Business Development Officer & Secretary | 40,250 | 1965 |
| Garry N. Lowenthal | Chief Financial Officer | 233,220 | 1959 |
| Bryan Monninger | Vice President of Sales & Distributor Relations | 0 | N/A |
| Andrea Cranston | Vice President of Marketing | 0 | N/A |
PetVivo Holdings, Inc. operates as a veterinary biotechnology and biomedical device enterprise, dedicated to the development, strategic licensing, and commercialization of innovative medical instruments and biomaterials. Its mission is to address diverse afflictions and maladies impacting animal health. The company's premier offering is Kush, an injectable solution for joints that veterinarians administer to mitigate the effects of osteoarthritis and mobility impairment in canine and equine patients. Furthermore, PetVivo's future product roadmap encompasses 17 distinct therapeutic devices, poised for both animal and human clinical applications. The firm maintains its corporate headquarters in Minneapolis, Minnesota.